KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 15 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,254,000 | -62.3% | 7,000,000 | -50.0% | 0.39% | -57.3% |
| Q2 2021 | $13,941,000 | -16.3% | 14,000,000 | -12.5% | 0.92% | -26.8% |
| Q1 2021 | $16,661,000 | -33.8% | 16,000,000 | -20.0% | 1.26% | -25.7% |
| Q4 2020 | $25,176,000 | -4.4% | 20,000,000 | -9.1% | 1.70% | -24.6% |
| Q3 2020 | $26,325,000 | -23.2% | 22,000,000 | -9.3% | 2.25% | -46.6% |
| Q2 2020 | $34,263,000 | -2.9% | 24,250,000 | 0.0% | 4.21% | +21.4% |
| Q1 2020 | $35,276,000 | -3.6% | 24,250,000 | -4.9% | 3.47% | +7.5% |
| Q4 2019 | $36,577,000 | – | 25,500,000 | – | 3.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 16,000,000 | $16,661,000 | 1.26% |
| Opti Capital Management, LP | 9,000,000 | $9,367,000 | 1.14% |
| Context Capital Management, LLC | 10,500 | $10,883,000 | 1.07% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | $20,429,000 | 0.20% |
| AQR Arbitrage LLC | 4,100,000 | $4,249,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 25,000,000 | $25,538,000 | 0.13% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 13,500,000 | $13,992,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 22,500,000 | $23,319,000 | 0.03% |
| Citadel Advisors | 48,300,000 | $50,405,000 | 0.01% |
| MACKAY SHIELDS LLC | 93,000 | $96,000 | 0.00% |